FNX - ETF AI Analysis
Top Page
First Trust Mid Cap Core AlphaDEX Fund (FNX)
Rating:68Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year, showing solid momentum for investors.
Broad Sector Diversification
Holdings are spread across many sectors, including financials, consumer cyclical, industrials, technology, and health care, which helps reduce the impact of weakness in any single area.
Multiple Strong-Performing Top Holdings
Several of the largest positions, particularly in energy and industrial-related companies, have shown strong year-to-date performance, supporting the fund’s overall results.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which means more of the returns are used to cover fees.
Heavy U.S. Concentration
With almost all assets in U.S. companies and very little international exposure, the fund is heavily tied to the U.S. market’s fortunes.
Notable Underperforming Holdings
Some top holdings, such as EPAM Systems and Genpact, have shown weak year-to-date performance, which can drag on the ETF’s overall returns.
FNX vs. SPDR S&P 500 ETF (SPY)
AUM1.31B
RegionNorth America
Expense Ratio0.62%
Beta0.89
IssuerFirst Trust
Inception DateMay 08, 2007
Dividend Yield1.02%
Asset ClassEquity
Index TrackedNASDAQ AlphaDEX Mid Cap Core Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume13,238
30 Day Avg. Volume11,359
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
170.48Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering449
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FNX Summary
FNX is an ETF that follows the NASDAQ AlphaDEX Mid Cap Core Index, focusing on medium‑sized U.S. companies across many sectors like financials, industrials, energy, and technology. It uses a rules-based approach to pick stocks with strong growth and value characteristics, giving investors a diversified mix of mid-sized businesses. Well-known holdings include HF Sinclair and CF Industries. Someone might invest in FNX to diversify beyond large, well-known companies and tap into the growth potential of mid-cap stocks. A key risk is that mid-cap stocks can be more volatile and can go up and down with the overall stock market.
How much will it cost me?The expense ratio for FNX is 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average for ETFs because FNX uses an actively managed, rules-based stock selection process to target mid-cap companies with growth and value potential.
What would affect this ETF?The FNX ETF, with its focus on mid-cap U.S. companies, could benefit from economic growth and innovation in sectors like technology, industrials, and consumer cyclical, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which can negatively impact financial and real estate sectors, or economic slowdowns that could affect mid-cap companies more than larger, established firms. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings, such as those in energy or materials.
FNX Top 10 Holdings
FNX is leaning into a classic mid-cap story, with a mix of rising energy names like HF Sinclair, APA, and SM Energy helping power the fund, even as their cash flow and leverage issues keep things a bit bumpy. On the growth side, Okta is a clear bright spot, riding strong momentum in security and AI, while health names like Amneal and Guardant Health add steady, if somewhat fragile, support. Retail and services players such as Gap and Genpact are more mixed, occasionally dragging on returns. Overall, it’s a U.S.-focused, broadly diversified mid-cap blend without a single sector dominating the stage.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HF Sinclair Corporation | 0.60% | $7.87M | $18.99B | 102.34% | 68 Neutral | |
| Epam Systems | 0.53% | $6.99M | $5.58B | -30.39% | 70 Neutral | |
| APA | 0.51% | $6.70M | $14.97B | 73.91% | 73 Outperform | |
| SM Energy | 0.51% | $6.63M | $8.07B | 29.64% | 72 Outperform | |
| Gap Inc | 0.48% | $6.34M | $7.66B | 7.54% | 76 Outperform | |
| Universal Health | 0.47% | $6.16M | $10.54B | -11.73% | 74 Outperform | |
| Genpact | 0.47% | $6.12M | $5.56B | -22.69% | 78 Outperform | |
| Okta | 0.47% | $6.12M | $34.12B | 115.40% | 75 Outperform | |
| Amneal Pharmaceuticals | 0.47% | $6.11M | $6.31B | 107.70% | 58 Neutral | |
| Guardant Health | 0.46% | $6.10M | $23.79B | 186.06% | 61 Neutral |
FNX Technical Analysis
Negative
―
Price Trends
142.62
Negative
141.77
Negative
136.87
Negative
Market Momentum
-2.09
Positive
31.65
Neutral
17.13
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FNX, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 139.36, equal to the 50-day MA of 142.62, and equal to the 200-day MA of 136.87, indicating a bearish trend. The MACD of -2.09 indicates Positive momentum. The RSI at 31.65 is Neutral, neither overbought nor oversold. The STOCH value of 17.13 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FNX.
FNX Peer Comparison
Comparison Results
Performance Comparison
FNX
First Trust Mid Cap Core AlphaDEX Fund
135.89
10.84
8.67%
FMDE
Fidelity Enhanced Mid Cap ETF
―
―
―
XMMO
Invesco S&P MidCap Momentum ETF
―
―
―
JHMM
John Hancock Multifactor Mid Cap ETF
―
―
―
XMHQ
Invesco S&P MidCap Quality ETF
―
―
―
DON
WisdomTree U.S. MidCap Dividend Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents